Researchers are testing an experimental vaccine called RBM-001 in healthy adults aged 18 to 55. The study aims to see if the vaccine is safe and triggers an immune response against COVID-19. Participants receive two doses, and researchers monitor for side effects and measure anti…
Phase 1 • Sponsor: Rock BioMedical, Inc. • Aim: Vaccine
Last updated Sep 04, 2026 00:00 UTC